Literature DB >> 17362249

Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study.

S Marinho1, A Simpson, L Lowe, P Kissen, C Murray, A Custovic.   

Abstract

BACKGROUND: There is a paucity of data on the prevalence, risk factors and natural history of rhinitis in early childhood.
OBJECTIVE: Within the context of a whole-population birth cohort we investigated the prevalence of and risk factors for current rhinoconjunctivitis (CRC) at age 5 years.
METHODS: Children were followed prospectively to age 5 years [questionnaires (n = 815), skin testing (n = 717), specific immunoglobulin E (n = 478), lung function (n = 711), dry air challenge (n = 556)]. Endotoxin and allergen exposures were measured in dust samples.
RESULTS: The prevalence of rhinitis ever, current rhinitis and rhinoconjunctivitis was 28.2%, 26.1%, and 12.1%, respectively. Asthma, wheeze and eczema coexisted with CRC (P < or = 0.01). In a multivariate model, maternal asthma (OR 2.38, 95% CI: 1.30-4.38, P = 0.005), paternal hay fever (1.96, 1.11-3.46, P = 0.02) and sensitization to grass (3.46, 1.86-6.42, P < 0.001) and cat (2.42, 1.14-5.18, P = 0.02) remained significant and independent associates of CRC. Whilst almost half of children with CRC were nonatopic, there was little difference in risk factors between atopic and nonatopic CRC. Amongst children with current wheeze, the presence of concurrent CRC had no effect on either severity or frequency of wheezy episodes. There was no difference in specific airway resistance, forced expiratory volume in 1 second (FEV(1)) or airway reactivity between children with and without CRC after adjustment for the presence of wheeze.
CONCLUSION: Family history of allergic disease and sensitization to inhalant allergens are risk factors for rhinoconjunctivitis in preschool children. In this age group, there is no association between the presence of rhinoconjunctivitis and severity of wheeze, increased airway reactivity and reduced lung function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362249     DOI: 10.1111/j.1398-9995.2006.01294.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  20 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 2.  Sex and atopy influences on the natural history of rhinitis.

Authors:  Ramesh J Kurukulaaratchy; Wilfried Karmaus; Syed Hasan Arshad
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-02

3.  Validating childhood symptoms with physician-diagnosed allergic rhinitis.

Authors:  Haejin Kim; Linda Levin; Grace K LeMasters; Manuel Villareal; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2012-02-28       Impact factor: 6.347

4.  Traffic pollution is associated with early childhood aeroallergen sensitization.

Authors:  Christopher D Codispoti; Grace K LeMasters; Linda Levin; Tiina Reponen; Patrick H Ryan; Jocelyn M Biagini Myers; Manuel Villareal; Jeff Burkle; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2014-12-10       Impact factor: 6.347

Review 5.  Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.

Authors:  Kevin Tse; Anthony A Horner
Journal:  Semin Immunopathol       Date:  2007-11-08       Impact factor: 9.623

Review 6.  Allergen tolerance versus the allergic march: the hygiene hypothesis revisited.

Authors:  Kevin Tse; Anthony A Horner
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

7.  Non-atopic rhinitis at age 6 is associated with subsequent development of asthma.

Authors:  Tara F Carr; Debra A Stern; Marilyn Halonen; Anne L Wright; Fernando D Martinez
Journal:  Clin Exp Allergy       Date:  2018-10-09       Impact factor: 5.018

8.  Methylation of IL-2 promoter at birth alters the risk of asthma exacerbations during childhood.

Authors:  J A Curtin; A Simpson; D Belgrave; A Semic-Jusufagic; A Custovic; F D Martinez
Journal:  Clin Exp Allergy       Date:  2013-03       Impact factor: 5.018

9.  Early protective and risk factors for allergic rhinitis at age 4½ yr.

Authors:  Bernt Alm; Emma Goksör; Hrefna Thengilsdottir; Rolf Pettersson; Per Möllborg; Gunnar Norvenius; Laslo Erdes; Nils Aberg; Göran Wennergren
Journal:  Pediatr Allergy Immunol       Date:  2011-03-08       Impact factor: 6.377

10.  Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age.

Authors:  Ali H Ziyab; Wilfried Karmaus; Mitra Yousefi; Susan Ewart; Eric Schauberger; John W Holloway; Hongmei Zhang; Syed Hasan Arshad
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.